BE647538A - - Google Patents

Info

Publication number
BE647538A
BE647538A BE647538A BE647538A BE647538A BE 647538 A BE647538 A BE 647538A BE 647538 A BE647538 A BE 647538A BE 647538 A BE647538 A BE 647538A BE 647538 A BE647538 A BE 647538A
Authority
BE
Belgium
Application number
BE647538A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CH567463A priority Critical patent/CH442293A/de
Priority to DE19641443636 priority patent/DE1443636A1/de
Priority to GB18463/64A priority patent/GB1027268A/en
Priority to FR973184A priority patent/FR1402961A/fr
Application filed filed Critical
Priority to BE647538A priority patent/BE647538A/xx
Priority to NL6404972A priority patent/NL6404972A/xx
Priority to FR984075A priority patent/FR3980M/fr
Priority to FR984076A priority patent/FR6464M/fr
Publication of BE647538A publication Critical patent/BE647538A/xx
Priority to US588287A priority patent/US3453296A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
BE647538A 1963-05-06 1964-05-05 BE647538A (de)

Priority Applications (9)

Application Number Priority Date Filing Date Title
CH567463A CH442293A (de) 1963-05-06 1963-05-06 Verfahren zur Herstellung neuer Verbindungen der Androstanreihe
DE19641443636 DE1443636A1 (de) 1963-05-06 1964-04-29 Verfahren zur Herstellung neuer Methylandrostene
GB18463/64A GB1027268A (en) 1963-05-06 1964-05-04 New methyl-androstenes and process for their manufacture
FR973184A FR1402961A (fr) 1963-05-06 1964-05-04 Procédé de préparation de nouveaux méthyl-androstènes
BE647538A BE647538A (de) 1963-05-06 1964-05-05
NL6404972A NL6404972A (de) 1963-05-06 1964-05-05
FR984075A FR3980M (de) 1963-05-06 1964-08-04
FR984076A FR6464M (de) 1963-05-06 1964-08-04
US588287A US3453296A (en) 1963-05-06 1966-10-21 Delta**1-7alpha-methyl-androstenes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH567463A CH442293A (de) 1963-05-06 1963-05-06 Verfahren zur Herstellung neuer Verbindungen der Androstanreihe
BE647538A BE647538A (de) 1963-05-06 1964-05-05

Publications (1)

Publication Number Publication Date
BE647538A true BE647538A (de) 1964-11-05

Family

ID=25655885

Family Applications (1)

Application Number Title Priority Date Filing Date
BE647538A BE647538A (de) 1963-05-06 1964-05-05

Country Status (7)

Country Link
US (1) US3453296A (de)
BE (1) BE647538A (de)
CH (1) CH442293A (de)
DE (1) DE1443636A1 (de)
FR (2) FR6464M (de)
GB (1) GB1027268A (de)
NL (1) NL6404972A (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996015794A1 (en) 1994-11-22 1996-05-30 Balance Pharmaceuticals, Inc. Compositions and methods for contraception and for treatment of benign gynecological disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB750834A (en) * 1953-02-11 1956-06-20 Syntex Sa Cyclopentanophenanthrene derivatives and a process for preparation of same
US3002005A (en) * 1958-10-24 1961-09-26 Upjohn Co 7-methylprogesterone
US3007947A (en) * 1959-12-29 1961-11-07 Searle & Co 17beta-hydroxyestr-1-en-3-ones and derivatives thereof

Also Published As

Publication number Publication date
DE1443636A1 (de) 1969-11-20
US3453296A (en) 1969-07-01
GB1027268A (en) 1966-04-27
NL6404972A (de) 1964-11-09
FR6464M (de) 1968-11-18
FR3980M (de) 1966-03-07
CH442293A (de) 1967-08-31

Similar Documents

Publication Publication Date Title
AT260747B (de)
FR3980M (de)
BE627012A (de)
BE626938A (de)
BE627023A (de)
BE627145A (de)
BE625825A (de)
BE634565A (de)
BE645364A (de)
BE626915A (de)
BE465565A (de)
BE645119A (de)
BE626358A (de)
BE625880A (de)
BE626826A (de)
BE644804A (de)
BE462764A (de)
BE31062A (de)
BE645323A (de)
BE630468A (de)
BE625136A (de)
BE507458A (de)
BE621232A (de)
BE533484A (de)
BE627151A (de)